SCHEMBL4855040

SCHEMBL4855040

Cc1cc(C)cc(-c2ccc(OCCN(C)C)c(C=CC(=O)c3ccccc3OC(C)C)c2)c1

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.49
ALDH1A1 P00352 3/20 0.49
BRPF1 P55201 1/20 0.43
AR P10275 2/20 0.41
ABCB1 P08183 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
SYK P43405 1/20 0.38
MAOB P27338 3/20 0.38
BCHE P06276 2/20 0.37
ACHE P22303 2/20 0.37
HRH1 P35367 1/20 0.37
IDO1 P14902 1/20 0.37
TDO2 P48775 1/20 0.37
MCHR1 Q99705 1/20 0.37
ESR1 P03372 1/20 0.36
IRAK4 Q9NWZ3 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4849810 0.92 ABCB1 (0.43) KDM4EALDH1A1ARABCB1SMN1; SMN2
SCHEMBL4855031 0.90 KDM4E (0.48) KDM4EALDH1A1BRPF1ARSMN1; SMN2
SCHEMBL4847178 0.90 KDM4E (0.48) KDM4EALDH1A1BRPF1ARSMN1; SMN2
SCHEMBL4849710 0.90 SYK (0.42) KDM4EALDH1A1ARABCB1SMN1; SMN2
SCHEMBL4853942 0.89 AR (0.45) KDM4EALDH1A1ARABCB1SMN1; SMN2
SCHEMBL4848288 0.88 AR (0.41) KDM4EALDH1A1ARABCB1SMN1; SMN2
SCHEMBL4846881 0.87 MAOB (0.48) KDM4EALDH1A1ARSMN1; SMN2TDP1
SCHEMBL14280886 0.86 SYK (0.43) KDM4EALDH1A1ARABCB1SMN1; SMN2
SCHEMBL4849980 0.86 SLC6A9 (0.42) KDM4EALDH1A1SMN1; SMN2SYKMAOB
SCHEMBL4847248 0.86 HTR7 (0.43) KDM4EALDH1A1ARSMN1; SMN2SYK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US claimed
US-7423181-B2 in particular against bacterial and parasitic infections, fungi, and helminths; improved metabolic and physiochemical properties, bioavailability, solubility; 3-[4-(2-Dimethylamino-ethoxy)-2'-trifluoromethyl-biphenyl-3-yl]-1-(2-dimethylaminomethyl-phenyl)-propenone LICA PHARMACEUTICALS A/S (DK) 2008-09-09 US disclosed
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US disclosed